Intracellular-signaling tumor-regression modeling of the pro-apoptotic receptor agonists dulanermin and conatumumab. (2012)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10928-012-9269-x
PubMed Identifier: 22932917
Publication URI: http://europepmc.org/abstract/MED/22932917
Type: Journal Article/Review
Volume: 39
Parent Publication: Journal of pharmacokinetics and pharmacodynamics
Issue: 5
ISSN: 1567-567X